Sigma Planning Corp’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,594
Closed -$353K 1279
2022
Q3
$353K Buy
12,594
+884
+8% +$27.4K 0.01% 884
2022
Q2
$353K Buy
+11,710
New +$402K 0.01% 909

Other funds holding BOUT

Sigma Planning Corp's BOUT Position: Q4 2022 in Review

Sigma Planning Corp sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q4 2022, closing a stake of 12,594 shares — an estimated $353K sold.

Sigma Planning Corp first reported a position in BOUT in Q2 2022 and held it in 2 quarters. The position peaked at $353K in Q3 2022. 8 funds tracked by Wall St. Rank hold BOUT as of Q4 2022.

  • Sigma Planning Corp reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q4 2022 after selling out during the quarter.
  • Sigma Planning Corp sold 12,594 CapForce IBD Breakout Opportunities ETF shares in Q4 2022, an estimated $353K.
  • Sigma Planning Corp first reported a position in CapForce IBD Breakout Opportunities ETF in Q2 2022 and held it in 2 quarters.
  • Sigma Planning Corp's CapForce IBD Breakout Opportunities ETF position peaked at $353K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q4 2022.

Based on Sigma Planning Corp's 13F filing for Q4 2022, filed 24 Jan 2023.